Riskpilot← Back to searchSign inGet full accessZEMANTIQ NUF
NUFActiveOrg 994804235Skolegata 7, 1606 FredrikstadBuying and selling of own real estate · NACE 6811Est. 20090 employeeswww.zemantiq.com
Revenue 2024
NOK 0
EBITDA margin
—
-4% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK 790K
+225% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -14K | -4% |
| Net profit | NOK 790K | +225% |
| Total assets | NOK 3,8M | +20% |
| Equity | NOK 3,8M | +20% |
| Employees | 0 | — |
Legal name
ZEMANTIQ NUF
Org number
994804235
Legal form
Norskregistrert Utenlandsk Foretak
NACE code
6811 · Buying and selling of own real estate
Founded
28. november 2009
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Martin thorsen ranang
Company purpose
Kjøp og salg av aksjer, eiendom og verdipapirer. It-konsulentvirksomhet. Utvikling og salg av programvare og programvaretjenester.
Address
Skolegata 7, 1606 Fredrikstad
Website
www.zemantiq.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −5 | −5 |
| EBITDA | −7 | −7 | −7 | −14 | −14 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | −7 | −7 | −14 | −14 |
| Net financials | 0 | 306 | 2 313 | 257 | 804 |
| Profit before tax | −7 | 299 | 2 306 | 243 | 790 |
| Tax | −0 | 5 | −0 | −0 | −0 |
| Net profit | −7 | 294 | 2 306 | 243 | 790 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 761 | 969 | 2 965 | 3 128 | 3 756 |
| Equity | 360 | 653 | 2 959 | 3 122 | 3 752 |
| Long-term debt | 401 | 311 | 0 | 0 | 0 |
| Short-term debt | 0 | 5 | 6 | 6 | 4 |
| Total debt | 401 | 316 | 6 | 6 | 4 |
EBITDA margin
-1428400.0%
This company
15.8%
Market median
-9040606% vs market
20202024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
21.0%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
78952500.0%
This company
8.1%
Market median
+974722122% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ST Deputy Member | Deputy Member | 2009 |
MT Chief Executive Officer | Chief Executive Officer | 2009 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ZEMANTIQ NUF 
Opinion Holding AsBoard members of ZEMANTIQ NUF also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Silje Treimo Persson | Deputy Member | 0 companies |
| Martin Thorsen Ranang | Chief Executive Officer | 0 companies |